Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-r...
Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier B.V
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier B.V
Subjects
More information
Scope and Contents
Contents
Highlights•This study shows that the addition of monthly IVMP to DMD significantly reduced relapse rates in RRMS patients. •In addition, these combinations were also safe, and most patients tolerated methylprednisolone as an add-on to DMD. •Monthly IVMP as an add-on therapy to interferon beta or GA seems to be safe and potentially useful. •Monthly...
Alternative Titles
Full title
Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1917664895
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1917664895
Other Identifiers
ISSN
0303-8467
E-ISSN
1872-6968
DOI
10.1016/j.clineuro.2017.06.016
